In February and March of 2012, Kalorama Information conducted a survey of
2,000 adults to ask them whether or not they would take a genetic test. This
report, Consumer Testing and the Future of DTC Genetic Testing provides those
results and compiles surveys from public and private sources to provide the
following insights:
Have Consumers Used a Self-Test Product?
Would They Take a Genetic Test?
Are They Concerned About Their Healthcare?
What Diseases Are They Most Concerned About?
Would Genetic Testing Increase Their Healthcare Usage?
In addition, the report provides information useful for marketers studying
this area including US Healthcare statistics and demographics, information on
doctor visits. The report discusses the increasing role of the 'Active
Healthcare Consumer' in healthcare markets. It also contains information on
the drug store industry in the U.S. and the role of test products in drug
stores. The report also discusses the recent attempts to market genetic DTC
products, the reaction of regulatory authorities and the activities of key
companies in the market in reaction to regulation. Using survey and sales
data, the report discusses the possible future of DTC testing efforts.
Table of Contents
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
Direct-to-consumer Testing and The Future of DTC Genetic Tests
Existing Self-Test Markets
DTC Genetic Tests
Aggressive Regulatory Action
Consumer Opinion
Conclusions
CHAPTER TWO: INTRODUCTION
Demographics
Declining Doctor Visits
Drop the Doctor But Keep the Pharmacist?
Consumer Worries
Concern About Health and Healthcare Costs
Baby Boomers More Concerned About Health
Drug Stores
Competitive Positions of Key Players
Increasing Space in the Drug Store For Tests
Role of the Pharmacist in Conducting Some Tests?
CHAPTER THREE: EXISTING SELF-TEST MARKETS
Highly Successful OTC Markets
Glucose
Pregnancy/Fertility
Moderately Successful OTC Test Markets
Fecal Occult Blood
Cholesterol
Implications
CHAPTER FOUR: DIRECT-TO-CONSUMER GENETIC TESTING: PROMISE AND REALITY
Background
Criticisms of DTC Testing
Scientific and Clinical Validity
False Advertising
GAO Investigation
Acu-Gen Biolab Lawsuit and Bankruptcy
Regulatory Activity
Pathway Genomics FDA Controversy
2011 FDA Warning Letters
Regulatory Action Targeting Suppliers
Actions in Response to FDA Letters
DTC Testing Companies
DeCode Genetics
23andMe
Genelex Corporation
Pathway Genomics
Navigenics
Lumigenix
Medigenomix
CHAPTER FIVE: CONSUMER OPINION
Healthcare Out of the Home
Consumer Worry Over Disease
Alzheimer's and Cancer Concerns
How Confident Are Consumers in Self Test Results?
Do Genetic Tests Increase Healthcare Usage?
NIH-led study
Would Consumers Take a Genetic Self-Test?
Loyola Study
Kalorama Survey of Adults
CHAPTER SIX: CONCLUSIONS
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Figure 1-1: Have You Used A Self-Test?
Figure 1-2: Kalorama Survey of Adults
CHAPTER TWO: INTRODUCTION
Figure 2-1: US Population
Figure 2-2: Doctor Visits, U.S. (millions of visits)
Figure 2-3: Have You Visited a Healthcare Professional? (DO, FP,
Internist, OBGY, Pharmacist)
Figure 2-4: Concern About Healthcare Cost and Barriers
Figure 2-5: How is Your Health? - AP Survey of Baby Boomers and Non-Boomers
Figure 2-6: Health Gotten Better/Worse Last Five Years? - Baby Boomers and
Non Baby Boomers
Table -2-2: U.S. Drug Store Sales,, 2003 - 2013
Table 2-3: Leading U.S. Drug Stores' Revenues and Market Share
CHAPTER THREE: EXISTING SELF-TEST MARKETS
Figure 3-1: Glucose Testing, 2010-2015
Figure 3-2: Pregnancy Testing, 2010-2015
Figure 3-3: Fecal Occult Blood Testing, 2010-2015
Figure 3-4: Cholesterol Testing, 2010-2015
CHAPTER FIVE: CONSUMER OPINION
Figure 5-1: Experian Simmons Survey: "Conditions I Don't Have But Feel I
am at Risk For"
Figure 5-2: Percent of Americans Concerned About Disease (Alzheimer's,
Cancer, Stroke, Diabetes)
Figure 5-3: Have You Used A Self-Test?
Table 5-1: Kalorama Survey Results - Would You Take a Genetic Test?
Consumer Testing and The Future of DTC Genetic Testing published by Kalorama Information in June 1, 2012. This report consists of 60 Pages and the price starts from US $ 995.
